SCHEMBL18870689

SCHEMBL18870689

CCc1cn2nc(B3OC(C)(C)C(C)(C)O3)cc(C)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17260845 0.83 ALDH1A1 (0.34) —
SCHEMBL27008059 0.81 — —
SCHEMBL27008083 0.76 ALDH1A1 (0.31) —
SCHEMBL19117247 0.76 LPL (0.32) —
SCHEMBL27008050 0.71 ALDH1A1 (0.31) —
SCHEMBL25435839 0.70 HPGD (0.31) —
SCHEMBL26814901 0.70 KDM4E (0.33) —
SCHEMBL24716631 0.70 FFAR1 (0.34) —
SCHEMBL25438598 0.68 ALDH1A1 (0.31) —
SCHEMBL27008199 0.68 SMPD3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3143025-B1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY HOFFMANN LA ROCHE (CH) 2019-10-09 — — EP disclosed
US-9969754-B2 Compounds for treating spinal muscular atrophy HOFFMANN-LA ROCHE INC. (US) 2018-05-15 — — US disclosed
US-20170197990-A1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY HOFFMANN-LA ROCHE INC. (US) 2017-07-13 — — US disclosed
WO-2017081111-A1 COMPOUNDS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS F. HOFFMANN-LA ROCHE AG (CH) 2017-05-18 — — WO disclosed
Send feedback